
    
      The study was submitted to Health Canada and received the letter of no objection. A
      randomized, double-blind, placebo-controlled study. The randomization scheme will be prepared
      and will be done by the pharmacy department at McMaster University. Ninety patients
      undergoing primary knee arthroplasty will be recruited from the preoperative clinic.
      Forty-five patients in each population will be allocated to a gabapentin group and the other
      forty-five to a placebo group.
    
  